Parametric Portfolio Associates’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.06M	Buy	111,362 +33,111	+42%	+$383K	﹤0.01%	2757
2021 Q4	$1.49M	Sell	78,251 -504	-0.6%	-$13.1K	﹤0.01%	2616
2021 Q3	$2.62M	Sell	78,755 -53,045	-40%	-$1.64M	﹤0.01%	2280
2021 Q2	$5.11M	Sell	131,800 -15,078	-10%	-$592K	﹤0.01%	1844
2021 Q1	$7.08M	Buy	146,878 +3,622	+3%	+$174K	﹤0.01%	1921
2020 Q4	$7.45M	Buy	143,256 +1,990	+1%	+$67.2K	﹤0.01%	1802
2020 Q3	$3.78M	Buy	141,266 +5,016	+4%	+$115K	﹤0.01%	2091
2020 Q2	$2.65M	Buy	136,250 +94,139	+224%	+$1.52M	﹤0.01%	2323
2020 Q1	$414K	Buy	42,111 +3,516	+9%	+$44.4K	﹤0.01%	3265
2019 Q4	$428K	Buy	38,595 +18,956	+97%	+$144K	﹤0.01%	3429
2019 Q3	$110K	Sell	19,639 -1,513	-7%	-$10.5K	﹤0.01%	3818
2019 Q2	$183K	Buy	21,152 +6,609	+45%	+$50K	﹤0.01%	3758
2019 Q1	$117K	Buy	+14,543	New	+$78.6K	﹤0.01%	3799
2017 Q4	–	Sell	-85,622	Closed	-$1.01M	–	3942
2017 Q3	$1.01M	Buy	85,622 +146	+0.2%	+$1.66K	﹤0.01%	3035
2017 Q2	$859K	Buy	85,476 +5,822	+7%	+$65.2K	﹤0.01%	3066
2017 Q1	$928K	Buy	+79,654	New	+$572K	﹤0.01%	2903
2016 Q1	–	Sell	-13,955	Closed	-$166K	–	4025
2015 Q4	$166K	Sell	13,955 -1,663	-11%	-$21K	﹤0.01%	3775
2015 Q3	$157K	Sell	15,618 -18,190	-54%	-$271K	﹤0.01%	3132
2015 Q2	$561K	Buy	+33,808	New	+$535K	﹤0.01%	3208